+1 (704) 266-3234

Global And Japan Cancer Treatment Drugs Market Insights, Forecast To 2027

Published on: Sep 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 160

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Global Cancer Treatment Drugs key players include Roche, Novartis, Celgene, Bristol-Myers Squibb, etc.
North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share over 30 percent.
In terms of product, Chemotherapy is the largest segment, with a share over 50%. And in terms of application, the largest application is Blood Cancer, followed by Breast Cancer, Prostate Cancer, Respiratory or Lung Cancer, etc.

Market Analysis and Insights: Global and Japan Cancer Treatment Drugs Market
This report focuses on global and Japan Cancer Treatment Drugs market.
In 2020, the global Cancer Treatment Drugs market size was US$ 164270 million and it is expected to reach US$ 296710 million by the end of 2027, with a CAGR of 8.8% during 2021-2027. In Japan the Cancer Treatment Drugs market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Cancer Treatment Drugs Scope and Market Size
Cancer Treatment Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Cancer Treatment Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others

Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences

1 Study Coverage
1.1 Cancer Treatment Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Cancer Treatment Drugs Market Size Growth Rate by Type
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy (Biologic Therapy)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cancer Treatment Drugs Market Size Growth Rate by Application
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Cancer Treatment Drugs Market Size, Estimates and Forecasts
2.1.1 Global Cancer Treatment Drugs Revenue 2016-2027
2.1.2 Global Cancer Treatment Drugs Sales 2016-2027
2.2 Global Cancer Treatment Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Cancer Treatment Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Cancer Treatment Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Cancer Treatment Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Cancer Treatment Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Cancer Treatment Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Cancer Treatment Drugs Revenue Forecast by Region (2022-2027)

3 Global Cancer Treatment Drugs Competitor Landscape by Players
3.1 Global Top Cancer Treatment Drugs Manufacturers by Sales
3.1.1 Global Cancer Treatment Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Cancer Treatment Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Cancer Treatment Drugs Manufacturers by Revenue
3.2.1 Key Cancer Treatment Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Cancer Treatment Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Cancer Treatment Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Cancer Treatment Drugs Revenue in 2020
3.2.6 Global Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Cancer Treatment Drugs Price by Manufacturers
3.4 Global Cancer Treatment Drugs Manufacturing Base Distribution, Product Types
3.4.1 Cancer Treatment Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Treatment Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Treatment Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Cancer Treatment Drugs Market Size by Type (2016-2021)
4.1.1 Global Cancer Treatment Drugs Sales by Type (2016-2021)
4.1.2 Global Cancer Treatment Drugs Revenue by Type (2016-2021)
4.1.3 Cancer Treatment Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Cancer Treatment Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Cancer Treatment Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Cancer Treatment Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Cancer Treatment Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Cancer Treatment Drugs Market Size by Application (2016-2021)
5.1.1 Global Cancer Treatment Drugs Sales by Application (2016-2021)
5.1.2 Global Cancer Treatment Drugs Revenue by Application (2016-2021)
5.1.3 Cancer Treatment Drugs Price by Application (2016-2021)
5.2 Cancer Treatment Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Cancer Treatment Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Cancer Treatment Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Cancer Treatment Drugs Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Cancer Treatment Drugs Market Size YoY Growth 2016-2027
6.1.1 Japan Cancer Treatment Drugs Sales YoY Growth 2016-2027
6.1.2 Japan Cancer Treatment Drugs Revenue YoY Growth 2016-2027
6.1.3 Japan Cancer Treatment Drugs Market Share in Global Market 2016-2027
6.2 Japan Cancer Treatment Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top Cancer Treatment Drugs Players by Sales (2016-2021)
6.2.2 Japan Top Cancer Treatment Drugs Players by Revenue (2016-2021)
6.3 Japan Cancer Treatment Drugs Historic Market Review by Type (2016-2021)
6.3.1 Japan Cancer Treatment Drugs Sales Market Share by Type (2016-2021)
6.3.2 Japan Cancer Treatment Drugs Revenue Market Share by Type (2016-2021)
6.3.3 Japan Cancer Treatment Drugs Price by Type (2016-2021)
6.4 Japan Cancer Treatment Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Cancer Treatment Drugs Sales Forecast by Type (2022-2027)
6.4.2 Japan Cancer Treatment Drugs Revenue Forecast by Type (2022-2027)
6.4.3 Japan Cancer Treatment Drugs Price Forecast by Type (2022-2027)
6.5 Japan Cancer Treatment Drugs Historic Market Review by Application (2016-2021)
6.5.1 Japan Cancer Treatment Drugs Sales Market Share by Application (2016-2021)
6.5.2 Japan Cancer Treatment Drugs Revenue Market Share by Application (2016-2021)
6.5.3 Japan Cancer Treatment Drugs Price by Application (2016-2021)
6.6 Japan Cancer Treatment Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Cancer Treatment Drugs Sales Forecast by Application (2022-2027)
6.6.2 Japan Cancer Treatment Drugs Revenue Forecast by Application (2022-2027)
6.6.3 Japan Cancer Treatment Drugs Price Forecast by Application (2022-2027)

7 North America
7.1 North America Cancer Treatment Drugs Market Size YoY Growth 2016-2027
7.2 North America Cancer Treatment Drugs Market Facts & Figures by Country
7.2.1 North America Cancer Treatment Drugs Sales by Country (2016-2021)
7.2.2 North America Cancer Treatment Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Cancer Treatment Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Cancer Treatment Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Cancer Treatment Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Cancer Treatment Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe Cancer Treatment Drugs Market Size YoY Growth 2016-2027
9.2 Europe Cancer Treatment Drugs Market Facts & Figures by Country
9.2.1 Europe Cancer Treatment Drugs Sales by Country (2016-2021)
9.2.2 Europe Cancer Treatment Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Cancer Treatment Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Cancer Treatment Drugs Market Facts & Figures by Country
10.2.1 Latin America Cancer Treatment Drugs Sales by Country (2016-2021)
10.2.2 Latin America Cancer Treatment Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Cancer Treatment Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Cancer Treatment Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Cancer Treatment Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Cancer Treatment Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Description and Business Overview
12.1.3 Roche Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Cancer Treatment Drugs Products Offered
12.1.5 Roche Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Cancer Treatment Drugs Products Offered
12.2.5 Novartis Recent Development
12.3 Celgene
12.3.1 Celgene Corporation Information
12.3.2 Celgene Description and Business Overview
12.3.3 Celgene Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Celgene Cancer Treatment Drugs Products Offered
12.3.5 Celgene Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Corporation Information
12.4.2 Bristol-Myers Squibb Description and Business Overview
12.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Amgen
12.5.1 Amgen Corporation Information
12.5.2 Amgen Description and Business Overview
12.5.3 Amgen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Amgen Cancer Treatment Drugs Products Offered
12.5.5 Amgen Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Description and Business Overview
12.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Johnson & Johnson Cancer Treatment Drugs Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Description and Business Overview
12.7.3 Pfizer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Pfizer Cancer Treatment Drugs Products Offered
12.7.5 Pfizer Recent Development
12.8 Takeda
12.8.1 Takeda Corporation Information
12.8.2 Takeda Description and Business Overview
12.8.3 Takeda Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Takeda Cancer Treatment Drugs Products Offered
12.8.5 Takeda Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Corporation Information
12.9.2 Eli Lilly Description and Business Overview
12.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Eli Lilly Cancer Treatment Drugs Products Offered
12.9.5 Eli Lilly Recent Development
12.10 AstraZeneca
12.10.1 AstraZeneca Corporation Information
12.10.2 AstraZeneca Description and Business Overview
12.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 AstraZeneca Cancer Treatment Drugs Products Offered
12.10.5 AstraZeneca Recent Development
12.11 Roche
12.11.1 Roche Corporation Information
12.11.2 Roche Description and Business Overview
12.11.3 Roche Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Roche Cancer Treatment Drugs Products Offered
12.11.5 Roche Recent Development
12.12 Merck & Co.
12.12.1 Merck & Co. Corporation Information
12.12.2 Merck & Co. Description and Business Overview
12.12.3 Merck & Co. Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Merck & Co. Products Offered
12.12.5 Merck & Co. Recent Development
12.13 Sanofi
12.13.1 Sanofi Corporation Information
12.13.2 Sanofi Description and Business Overview
12.13.3 Sanofi Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Sanofi Products Offered
12.13.5 Sanofi Recent Development
12.14 Bayer
12.14.1 Bayer Corporation Information
12.14.2 Bayer Description and Business Overview
12.14.3 Bayer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Bayer Products Offered
12.14.5 Bayer Recent Development
12.15 Biogen Idec
12.15.1 Biogen Idec Corporation Information
12.15.2 Biogen Idec Description and Business Overview
12.15.3 Biogen Idec Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Biogen Idec Products Offered
12.15.5 Biogen Idec Recent Development
12.16 Eisai
12.16.1 Eisai Corporation Information
12.16.2 Eisai Description and Business Overview
12.16.3 Eisai Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Eisai Products Offered
12.16.5 Eisai Recent Development
12.17 Teva
12.17.1 Teva Corporation Information
12.17.2 Teva Description and Business Overview
12.17.3 Teva Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Teva Products Offered
12.17.5 Teva Recent Development
12.18 Otsuka
12.18.1 Otsuka Corporation Information
12.18.2 Otsuka Description and Business Overview
12.18.3 Otsuka Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Otsuka Products Offered
12.18.5 Otsuka Recent Development
12.19 Merck KGaA
12.19.1 Merck KGaA Corporation Information
12.19.2 Merck KGaA Description and Business Overview
12.19.3 Merck KGaA Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Merck KGaA Products Offered
12.19.5 Merck KGaA Recent Development
12.20 Ipsen
12.20.1 Ipsen Corporation Information
12.20.2 Ipsen Description and Business Overview
12.20.3 Ipsen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Ipsen Products Offered
12.20.5 Ipsen Recent Development
12.21 AbbVie
12.21.1 AbbVie Corporation Information
12.21.2 AbbVie Description and Business Overview
12.21.3 AbbVie Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.21.4 AbbVie Products Offered
12.21.5 AbbVie Recent Development
12.22 Gilead Sciences
12.22.1 Gilead Sciences Corporation Information
12.22.2 Gilead Sciences Description and Business Overview
12.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Gilead Sciences Products Offered
12.22.5 Gilead Sciences Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Cancer Treatment Drugs Industry Trends
13.2 Cancer Treatment Drugs Market Drivers
13.3 Cancer Treatment Drugs Market Challenges
13.4 Cancer Treatment Drugs Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Treatment Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Cancer Treatment Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Chemotherapy
Table 3. Major Manufacturers of Targeted Therapy
Table 4. Major Manufacturers of Immunotherapy
Table 5. Major Manufacturers of Hormonal Therapy (Biologic Therapy)
Table 6. Major Manufacturers of Others
Table 7. Global Cancer Treatment Drugs Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 8. Global Cancer Treatment Drugs Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Cancer Treatment Drugs Sales by Regions (2016-2021) & (K Pcs)
Table 10. Global Cancer Treatment Drugs Sales Market Share by Regions (2016-2021)
Table 11. Global Cancer Treatment Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Cancer Treatment Drugs Sales Forecast by Region (2022-2027) & (K Pcs)
Table 13. Global Cancer Treatment Drugs Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Cancer Treatment Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Cancer Treatment Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Cancer Treatment Drugs Sales by Manufacturers (2016-2021) (K Pcs)
Table 17. Global Cancer Treatment Drugs Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Cancer Treatment Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 19. Cancer Treatment Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Cancer Treatment Drugs Revenue Share by Manufacturers (2016-2021)
Table 21. Global Cancer Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Cancer Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Treatment Drugs as of 2020)
Table 23. Key Manufacturers Cancer Treatment Drugs Price (2016-2021) (USD/Pcs)
Table 24. Cancer Treatment Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Cancer Treatment Drugs Product Type
Table 26. Date of International Manufacturers Enter into Cancer Treatment Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Cancer Treatment Drugs Sales by Type (2016-2021) (K Pcs)
Table 29. Global Cancer Treatment Drugs Sales Share by Type (2016-2021)
Table 30. Global Cancer Treatment Drugs Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Cancer Treatment Drugs Revenue Share by Type (2016-2021)
Table 32. Cancer Treatment Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 33. Global Cancer Treatment Drugs Sales Forecast by Type (2022-2027) & (K Pcs)
Table 34. Global Cancer Treatment Drugs Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Cancer Treatment Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Cancer Treatment Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Cancer Treatment Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 38. Global Cancer Treatment Drugs Sales by Application (2016-2021) (K Pcs)
Table 39. Global Cancer Treatment Drugs Sales Share by Application (2016-2021)
Table 40. Global Cancer Treatment Drugs Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Cancer Treatment Drugs Revenue Share by Application (2016-2021)
Table 42. Cancer Treatment Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 43. Global Cancer Treatment Drugs Sales Forecast by Application (2022-2027) & (K Pcs)
Table 44. Global Cancer Treatment Drugs Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Cancer Treatment Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Cancer Treatment Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Cancer Treatment Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 48. Japan Cancer Treatment Drugs Sales (K Pcs) of Key Companies (2016-2021)
Table 49. Japan Cancer Treatment Drugs Sales Share by Company (2016-2021)
Table 50. Japan Cancer Treatment Drugs Revenue (US$ Million) by Company (2016-2021)
Table 51. Japan Cancer Treatment Drugs Revenue Share by Company (2016-2021)
Table 52. Japan Cancer Treatment Drugs Sales (K Pcs) by Type (2016-2021)
Table 53. Japan Cancer Treatment Drugs Sales Share by Type (2016-2021)
Table 54. Japan Cancer Treatment Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. Japan Cancer Treatment Drugs Price (USD/Pcs) by Type (2016-2021)
Table 56. Japan Cancer Treatment Drugs Sales (K Pcs) by Type (2022-2027)
Table 57. Japan Cancer Treatment Drugs Sales Share by Type (2022-2027)
Table 58. Japan Cancer Treatment Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. Japan Cancer Treatment Drugs Revenue Share by Type (2022-2027)
Table 60. Japan Cancer Treatment Drugs Price (USD/Pcs) by Type (2022-2027)
Table 61. Japan Cancer Treatment Drugs Sales (K Pcs) by Application (2016-2021)
Table 62. Japan Cancer Treatment Drugs Sales Share by Application (2016-2021)
Table 63. Japan Cancer Treatment Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. Japan Cancer Treatment Drugs Price (USD/Pcs) by Application (2016-2021)
Table 65. Japan Cancer Treatment Drugs Sales (K Pcs) by Application (2022-2027)
Table 66. Japan Cancer Treatment Drugs Sales Share by Application (2022-2027)
Table 67. Japan Cancer Treatment Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. Japan Cancer Treatment Drugs Revenue Share by Application (2022-2027)
Table 69. Japan Cancer Treatment Drugs Price (USD/Pcs) by Application (2022-2027)
Table 70. North America Cancer Treatment Drugs Sales by Country (2016-2021) & (K Pcs)
Table 71. North America Cancer Treatment Drugs Sales Market Share by Country (2016-2021)
Table 72. North America Cancer Treatment Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Cancer Treatment Drugs Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Cancer Treatment Drugs Sales by Region (2016-2021) & (K Pcs)
Table 75. Asia Pacific Cancer Treatment Drugs Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Cancer Treatment Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Cancer Treatment Drugs Revenue Market Share by Region (2016-2021)
Table 78. Europe Cancer Treatment Drugs Sales by Country (2016-2021) & (K Pcs)
Table 79. Europe Cancer Treatment Drugs Sales Market Share by Country (2016-2021)
Table 80. Europe Cancer Treatment Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Cancer Treatment Drugs Revenue Market Share by Country (2016-2021)
Table 82. Latin America Cancer Treatment Drugs Sales by Country (2016-2021) & (K Pcs)
Table 83. Latin America Cancer Treatment Drugs Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Cancer Treatment Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Cancer Treatment Drugs Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Cancer Treatment Drugs Sales by Country (2016-2021) & (K Pcs)
Table 87. Middle East and Africa Cancer Treatment Drugs Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Cancer Treatment Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Country (2016-2021)
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 93. Roche Cancer Treatment Drugs Product
Table 94. Roche Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 98. Novartis Product
Table 99. Novartis Recent Development
Table 100. Celgene Corporation Information
Table 101. Celgene Description and Business Overview
Table 102. Celgene Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 103. Celgene Product
Table 104. Celgene Recent Development
Table 105. Bristol-Myers Squibb Corporation Information
Table 106. Bristol-Myers Squibb Description and Business Overview
Table 107. Bristol-Myers Squibb Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 108. Bristol-Myers Squibb Product
Table 109. Bristol-Myers Squibb Recent Development
Table 110. Amgen Corporation Information
Table 111. Amgen Description and Business Overview
Table 112. Amgen Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Amgen Product
Table 114. Amgen Recent Development
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Business Overview
Table 117. Johnson & Johnson Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Johnson & Johnson Product
Table 119. Johnson & Johnson Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Pfizer Product
Table 124. Pfizer Recent Development
Table 125. Takeda Corporation Information
Table 126. Takeda Description and Business Overview
Table 127. Takeda Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Takeda Product
Table 129. Takeda Recent Development
Table 130. Eli Lilly Corporation Information
Table 131. Eli Lilly Description and Business Overview
Table 132. Eli Lilly Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Eli Lilly Product
Table 134. Eli Lilly Recent Development
Table 135. AstraZeneca Corporation Information
Table 136. AstraZeneca Description and Business Overview
Table 137. AstraZeneca Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. AstraZeneca Product
Table 139. AstraZeneca Recent Development
Table 140. Astellas Corporation Information
Table 141. Astellas Description and Business Overview
Table 142. Astellas Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Astellas Product
Table 144. Astellas Recent Development
Table 145. Merck & Co. Corporation Information
Table 146. Merck & Co. Description and Business Overview
Table 147. Merck & Co. Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 148. Merck & Co. Product
Table 149. Merck & Co. Recent Development
Table 150. Sanofi Corporation Information
Table 151. Sanofi Description and Business Overview
Table 152. Sanofi Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 153. Sanofi Product
Table 154. Sanofi Recent Development
Table 155. Bayer Corporation Information
Table 156. Bayer Description and Business Overview
Table 157. Bayer Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Bayer Product
Table 159. Bayer Recent Development
Table 160. Biogen Idec Corporation Information
Table 161. Biogen Idec Description and Business Overview
Table 162. Biogen Idec Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Biogen Idec Product
Table 164. Biogen Idec Recent Development
Table 165. Eisai Corporation Information
Table 166. Eisai Description and Business Overview
Table 167. Eisai Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Eisai Product
Table 169. Eisai Recent Development
Table 170. Teva Corporation Information
Table 171. Teva Description and Business Overview
Table 172. Teva Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Teva Product
Table 174. Teva Recent Development
Table 175. Otsuka Corporation Information
Table 176. Otsuka Description and Business Overview
Table 177. Otsuka Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Otsuka Product
Table 179. Otsuka Recent Development
Table 180. Merck KGaA Corporation Information
Table 181. Merck KGaA Description and Business Overview
Table 182. Merck KGaA Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Merck KGaA Product
Table 184. Merck KGaA Recent Development
Table 185. Ipsen Corporation Information
Table 186. Ipsen Description and Business Overview
Table 187. Ipsen Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. Ipsen Product
Table 189. Ipsen Recent Development
Table 190. AbbVie Corporation Information
Table 191. AbbVie Description and Business Overview
Table 192. AbbVie Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 193. AbbVie Product
Table 194. AbbVie Recent Development
Table 195. Gilead Sciences Corporation Information
Table 196. Gilead Sciences Description and Business Overview
Table 197. Gilead Sciences Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 198. Gilead Sciences Product
Table 199. Gilead Sciences Recent Development
Table 200. Cancer Treatment Drugs Market Trends
Table 201. Cancer Treatment Drugs Market Drivers
Table 202. Cancer Treatment Drugs Market Challenges
Table 203. Cancer Treatment Drugs Market Restraints
Table 204. Cancer Treatment Drugs Customers List
Table 205. Cancer Treatment Drugs Distributors List
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Treatment Drugs Product Picture
Figure 2. Global Cancer Treatment Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Chemotherapy Product Picture
Figure 4. Targeted Therapy Product Picture
Figure 5. Immunotherapy Product Picture
Figure 6. Hormonal Therapy (Biologic Therapy) Product Picture
Figure 7. Others Product Picture
Figure 8. Global Cancer Treatment Drugs Sales Market Share by Application in 2020 & 2027
Figure 9. Blood Cancer
Figure 10. Breast Cancer
Figure 11. Gastrointestinal Cancer
Figure 12. Prostate Cancer
Figure 13. Respiratory or Lung Cancer
Figure 14. Others
Figure 15. Cancer Treatment Drugs Report Years Considered
Figure 16. Global Cancer Treatment Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Cancer Treatment Drugs Market Size 2016-2027 (US$ Million)
Figure 18. Global Cancer Treatment Drugs Sales 2016-2027 (K Pcs)
Figure 19. Global Cancer Treatment Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 20. Global Cancer Treatment Drugs Sales Market Share by Region (2016-2021)
Figure 21. Global Cancer Treatment Drugs Sales Market Share by Region in 2020
Figure 22. Global Cancer Treatment Drugs Revenue Market Share by Region (2016-2021)
Figure 23. Global Cancer Treatment Drugs Revenue Market Share by Region in 2020
Figure 24. Global Cancer Treatment Drugs Sales Share by Manufacturer in 2020
Figure 25. The Top 10 and 5 Players Market Share by Cancer Treatment Drugs Revenue in 2020
Figure 26. Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 27. Global Cancer Treatment Drugs Sales Market Share by Type (2016-2021)
Figure 28. Global Cancer Treatment Drugs Sales Market Share by Type in 2020
Figure 29. Global Cancer Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 30. Global Cancer Treatment Drugs Revenue Market Share by Type in 2020
Figure 31. Global Cancer Treatment Drugs Sales Market Share by Application (2016-2021)
Figure 32. Global Cancer Treatment Drugs Sales Market Share by Application in 2020
Figure 33. Global Cancer Treatment Drugs Revenue Market Share by Application (2016-2021)
Figure 34. Global Cancer Treatment Drugs Revenue Market Share by Application in 2020
Figure 35. Japan Cancer Treatment Drugs Sales Growth Rate 2016-2027 (K Pcs)
Figure 36. Japan Cancer Treatment Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 37. Japan Cancer Treatment Drugs Market Share in Global Market 2016-2027
Figure 38. Japan 5 and 10 Largest Cancer Treatment Drugs Players Market Share by Revenue in Cancer Treatment Drugs in 2020
Figure 39. Japan Cancer Treatment Drugs Revenue Share by Type (2016-2021)
Figure 40. Japan Cancer Treatment Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 41. Japan Cancer Treatment Drugs Revenue Share by Application (2016-2021)
Figure 42. Japan Cancer Treatment Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 43. North America Cancer Treatment Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 44. North America Cancer Treatment Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 45. North America Cancer Treatment Drugs Sales Market Share by Country in 2020
Figure 46. North America Cancer Treatment Drugs Revenue Market Share by Country in 2020
Figure 47. U.S. Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 48. U.S. Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Canada Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 50. Canada Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Europe Cancer Treatment Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 52. Europe Cancer Treatment Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 53. Europe Cancer Treatment Drugs Sales Market Share by Country in 2020
Figure 54. Europe Cancer Treatment Drugs Revenue Market Share by Country in 2020
Figure 55. Germany Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 56. Germany Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. France Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 58. France Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. U.K. Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 60. U.K. Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Italy Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 62. Italy Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Russia Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 64. Russia Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Asia Pacific Cancer Treatment Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 66. Asia Pacific Cancer Treatment Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 67. Asia Pacific Cancer Treatment Drugs Sales Market Share by Region in 2020
Figure 68. Asia Pacific Cancer Treatment Drugs Revenue Market Share by Region in 2020
Figure 69. China Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 70. China Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Japan Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 72. Japan Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. South Korea Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 74. South Korea Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. India Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 76. India Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Australia Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 78. Australia Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. China Taiwan Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 80. China Taiwan Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Indonesia Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 82. Indonesia Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Thailand Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 84. Thailand Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Malaysia Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 86. Malaysia Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Cancer Treatment Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 88. Latin America Cancer Treatment Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Cancer Treatment Drugs Sales Market Share by Country in 2020
Figure 90. Latin America Cancer Treatment Drugs Revenue Market Share by Country in 2020
Figure 91. Mexico Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 92. Mexico Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 94. Brazil Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 96. Argentina Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Cancer Treatment Drugs Sales Growth Rate 2016-2021 (K Pcs)
Figure 98. Middle East and Africa Cancer Treatment Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 99. Middle East and Africa Cancer Treatment Drugs Sales Market Share by Country in 2020
Figure 100. Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Country in 2020
Figure 101. Turkey Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 102. Turkey Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Saudi Arabia Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 104. Saudi Arabia Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. UAE Cancer Treatment Drugs Sales Growth Rate (2016-2021) (K Pcs)
Figure 106. UAE Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. Cancer Treatment Drugs Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.